About the Authors
- Vita W. Jongen
-
Roles Formal analysis, Visualization, Writing – original draft
* E-mail: vjongen@ggd.amsterdam.nl
Affiliation Department of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands
- Maarten F. Schim van der Loeff
-
Roles Formal analysis, Supervision, Writing – review & editing
Affiliations Department of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands, Amsterdam UMC, Univ of Amsterdam, Internal Medicine, Amsterdam Infection and Immunity (AII), Amsterdam, The Netherlands
- Matthys H. Botha
-
Roles Investigation, Writing – review & editing
Affiliation Department of Obstetrics and Gynaecology, Stellenbosch University, Cape Town, South Africa
- Staci L. Sudenga
-
Roles Conceptualization, Writing – review & editing
Affiliation Division of Epidemiology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America
- Martha E. Abrahamsen
-
Roles Data curation, Writing – review & editing
Affiliation Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, Tampa, Florida, United States of America
- Anna R. Giuliano
-
Roles Conceptualization, Writing – review & editing
Affiliation Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, Tampa, Florida, United States of America
Competing Interests
The authors have read the journal’s policy and have the following competing interests: ARG received a grant (IISP39582) from Merck during the course of this study and is a member of Merck research advisory boards. This does not alter our adherence to PLOS ONE policies on sharing data and materials. ARG and SLS received research funding from Merck outside the scope of this study. MFSvdL received research funding from Sanofi-Pasteur MSD; he is a co-investigator in a Sanofi-Pasteur-MSD HPV vaccine trial; he sat on a vaccine advisory board of GSK; his institution received in-kind contribution for an HPV study from Stichting Pathologie Onderzoek en Ontwikkeling (SPOO); his institution receives research funding from Janssen Infectious Diseases and Vaccines. There are no patents, products in development or marketed products associated with this research to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The other authors declare no conflicts of interest.